Iovance Biotherapeutics: Q4 Earnings Snapshot

robot
Abstract generation in progress

Iovance Biotherapeutics: Q4 Earnings Snapshot

Associated Press Finance

Tue, February 24, 2026 at 9:26 PM GMT+9 1 min read

In this article:

IOVA

+0.70%

SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Tuesday reported a loss of $71.9 million in its fourth quarter.

On a per-share basis, the San Carlos, California-based company said it had a loss of 18 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

The biotechnology company posted revenue of $86.7 million in the period.

For the year, the company reported a loss of $391 million, or $1.09 per share. Revenue was reported as $263.5 million.


This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on IOVA at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin